ea0032p186 | Cardiovascular Endocrinology & Lipid Metabolism | ECE2013
Sonmez Alper
, Taslipinar Abdullah
, Aydogdu Aydogan
, Tapan Serkan
, Meric Coskun
, Basaran Yalcin
, Sertoglu Erdim
, Yilmaz Mahmut I
, Serdar Muhittin A
, Ozgurtas Taner
, Bolu Erol
, Kutlu Mustafa
Objective: Metabolic disorders are common in patients with hypogonadism. Testosterone replacement therapy (TRT) significantly improves symptoms of testosterone deprivation such as mood, libido or musculoscelatal power. However, whether the metabolic and cardiovascular risk is improved is not clearly known. We aimed to search for the metabolic and cardiovascular effects of TRT.Design: Prospective study, performed in the outpatient units of Gulhane Medical...